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ABSTRACT 
Effect of adaptive replanning on ORGAN AT RISK doses at 
40 Gy in head and neck cancers. 
Aim: 
To evaluate the dose volume histogram datas in patients diagnosed as stage 
III/IV cancer in the Nasopharynx /Oropharynx /Hypopharynx. All patients 
are treated with IMRT using planning CT images and evaluated with CBCT 
images  during the course of treatment.  
Materials and methods :  
This is a prospective study of DOSIMETRIC analysis done at our institute 
between March 2017 to August 2017.We evaluate the TCP and NTCP datas 
calculated based on equivalent uniform dose(EUD). Cone beam CT images 
are taken for patients at 40Gy and organ at risk (OAR) such as spinal cord, 
brainstorm, parotid gland, mandible are contoured by the same radiation 
oncologist on the CBCT image set and deformed to initial planning CT. 
DVH generated for these structures from initial clinical plan was evaluated - 
NTCP and TCP are calculated.  
 
 
Description :                                                                                                             
In this study we have evaluated that the mean average parotid volume dose 
received has increased by 10%. The Median dose increase by 7 %.  
Conclusion : 
In this study we observed a significant increase in NTCP if the same clinical 
plan continued beyond 40Gy. 
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I.INTRODUCTION: 
 
The incidence of head and neck cancers are on the rise, and hence awareness is 
required among treating oncologists to cater different means of approach, to ensure 
in such a way that patients treated with concurrent chemoradiation should  have 
better quality of life, inspite of improving overall outcome after the end of 
treatment. Head and neck cancers employ multidisciplinary approach, and 
radiation plays a major role as most of the head and neck cancers require organ 
preservation to ensure an adequate quality of life. 
 
The era of Organ preservation in Head and neck cancers dates back to the Veteran 
Affairs Laryngeal study trial, in which patients treated with surgery led to 
unfortunate side effects like dependency with feeding tube, tracheostomy and the 
rest. This led to search of functional preservation, and with concurrent 
chemoradiation, the outcome was similar with that of surgery, with patients having 
an improved quality of life inspite of improved overall survival.  
 
a.Incidence of head and neck cancers from 1982 to till date has been given below 
which clearly illustrates a rising trend over the years.  
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INCIDENCE OF  HYPOPHARYNGEAL CANCER:
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                    INCIDENCE OF OROPHARYNGEAL CANCER: 
Cancer Oropharynx Period: 1982-2014 Male    : 1,377
ICD-10: C09-C10 Cases:  1,616 Female:    239
Oropharynx cancer
1982-
1986
1987-
1991
1992-
1996
1997-
2001
2002-
2006
2007-
2011
2012-
2014
Annual No. of cases:     Men 19 30 37 42 61 67 67
Women 5 7 5 8 7 10 10
% to total cancers 0.9 1.2 1.2 1.2 1.4 1.4 2.0
Men: CIR / 100,000 1.1 1.5 1.8 1.9 2.7 2.9 2.8
ASR / 100,000 1.5 2.2 2.4 2.4 3.0 3.0 2.8
Cumulative Risk % - One in 526 364 334 322 272 261
Women: CIR / 100,000 0.3 0.4 0.3 0.4 0.4 0.4 0.5
ASR / 100,000 0.4 0.5 0.3 0.5 0.4 0.5 0.4
Cumulative Risk % - One in 1818 1587 2222 1923 2703 1724 1716
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INCIDENCE OF NASOPHARYNGEAL CANCER: 
Cancer Nsaopharynx Period: 1982-2014 Male    : 466
ICD-10: C11 Cases:  690 Female:  224
Oropharynx cancer
1982-
1986
1987-
1991
1992-
1996
1997-
2001
2002-
2006
2007-
2011
2012-
2014
Annual No. of cases:     Men 11 12 14 17 15 17 14
Women 16 17 19 24 22 26 10
% to total cancers 0.7 0.6 0.6 0.7 0.5 0.5 0.4
Men: CIR / 100,000 0.6 0.6 0.7 0.8 0.7 0.7 0.6
ASR / 100,000 0.7 0.7 0.8 0.8 0.7 0.7 0.4
Cumulative Risk % - One in 1538 1316 1149 1176 1316 1220 1613
Women: CIR / 100,000 0.3 0.3 0.3 0.3 0.3 0.4 0.4
ASR / 100,000 0.4 0.3 0.3 0.3 0.3 0.4 0.4
Cumulative Risk % - One in 3125 2941 3704 3226 3226 2326 2174
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b.EVOLUTION OF RADIATION TECHNIQUES: 
Radiation therapy started with conventional two opposing fields, unilateral 
wedge fields and three field technique, which led to appreciable morbidity which 
had a detrimental effect in quality of life post treatment. Over the years, Radiation 
treatment has seen a significant improvement with new techniques such as 
conformal therapy, intensity modulated radiation therapy, volumetric modulated 
arc therapy, Stereotactic therapy, etc. There was also considerable improvement in 
interstitial brachytherapy with switch over from low dose rate to high dose rate 
brachytherapy leading to significant reduction in treatment times, outpatient 
procedures which resulted in significant evolution of treatment techniques. Organ 
preservation is a significant task for radiation oncologists, because of the fact that 
improved treatment techniques does also have some unwanted effects such as 
increased integral dose, which theoretically has demerits, and also because of the 
fact that long term data in newer techniques are lacking to exactly pinpoint long 
term effects of the same. Hence there is a growing need among oncologists not 
only to compare overall survival and disease free survival, but also functional 
morbidity, which helps in assessing the quality of life that are experienced by the 
patients.  
One of the most important factors that is usually overlooked is patient’s 
nutrition. The common complaint among head and neck cancer patients is 
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dysphagia, which in turn leads to poor nutrition, thereby leading to loss of weight 
and altered body mass ratio, thereby causing major impact on treatment delivery. 
Numerous studies have emphasized the fact that Intensity modulated radiotherapy 
can minimize dose to organs at risk, especially the parotid glands, which was the 
major component of PARSPORT trial, without compromising tumour dose. Non 
randomized trials also suggests that xerostomia, was less common among patients 
treated with newer techniques compared to that of conventional and conformal 
radiotherapy. 
 In the past, head and neck cancers have lower percentage of local control, 
due to various factors. Also, conventional treatment led to increased dose to the 
organs at risk. One of the studies showed that 5 year local control was 84%  with 
increase in radiation dose to the tumour area, but also noticed the fact that such 
patients, had increased toxicity profile due to irradiation of normal structures with 
higher dosage. Hence newer techniques were developed to offset and curb the 
problem.    
        Radiotherapy has its roots in the discipline of radiology from which branch of 
cancer treatment –radiation oncology developed. From time Roentgen discovered 
xrays 2 dimensional images of human body provided unprecedented images of 
bony land marks allowing the radiologist to locate the internal organs. This helped 
the radiation oncologist that with the advent of planar radiograph they  planned the 
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cancer treatments by collimating the rectangular fields encompassing the tumor 
location
2
.  Human  anatomy however is three dimensional ,by treating a large 
volume  of  normal tissue  the dose achieved by the  structure is very high that the 
treating physicians themselves have  limited  by the dose received by the normal 
tissues.  
C.EVOLUTION OF IMRT: 
Evolution of  radiotherapy from 2D planning to 3D c onformal treating plan came 
after the development  of  computed tomography  techniques.  
 In three dimensional (3D CRT ) conformal technique a target volume is defined 
by the xray beams positioned in a two dimensional (2D ) beams eye view of the 
target.  During the planning the patients  are  positioned  with immobilization 
devices and images are taken in their treatment palnning  positions.  
These images are reconstructed ,data sets acquired, using the spiral CT scanners 
which are capable of acquiring 50-100 transverse image planes which can be 
spaced from 2mm to 5mm cuts according to the desire of the treating physician  .  
The data transmission sets are equipped to reconstruct the images to 3 dimensional 
data consisting of  Hounsfield numbers associated  with Voxels.  
DICOM-Digital imaging and communication in medicine software is being used 
for exchange of data sets from one  vendor to the other .This allows the radiation 
oncologist to plan  and treat the patient  in another vendor
1
.  
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The 3 D planning treatment has evolved into Intensity modulated radiotherapy 
(IMRT) which evolved in clinical practice in the early 1980’s. But the widespread 
usage of the IMRT happened only in the early 1990’s in the United States with 
commercially available peacock IMRT planning system and MIMiC fan beam 
delivery device (NOMOS RADIATION Oncology Division ,Cranberry Township 
,PA)
2,3
. Basically the  common feature of  IMRT  is that they try to have the 
control over the three dimensional dose distribution  by having a large number of  
independent
  
fields either fixed or from multiple arcs in different positions.  With 
time there came MLC-Multi leaf collimator based IMRT . MLC’s allows the 
adjustment of the treatment aperture which is best suited for dynamic radiation 
beam.   
IMRT techniques are broadly classified into : 
 1.Fixed gantry IMRT  
2.Arc based  IMRT  
Fixed gantry IMRT  treatment can be either a MLC based delivery  and  
Compensator based delivery .  
MLC based delivery technique has two types of treatment delivery  technique step 
and shoot delivery & Dynamic delivery.  
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Arc based IMRT can be either FAN beam IMRT and  cone beam IMRT .               
Fan beam therapy encompases MIMiC slice by slice delivery and helical 
tomotherapy.  CONE beam IMRT can be aperture modulated arc therapy (single 
arc)  and  intensity modulated arc therapy (multiple arcs).
1 
Intensity modulated radiotherapy  IMRT adds a degree of freedom to the treating 
physicians in RT planning thereby provides an effective means to produce tightly 
conformal dose distributions in complex treatment situations.  
Advantages of  IMRT:  
IMRT has the ability to produce high conformal dose distributions which are  
concave shaped isodose distributions which closely follow the shapes ,boundaries 
of target tissues . But the conformal technique has convex shaped dose 
distributions. Becaue of these highly concave dose distributions we can achieve 
high tumor control rate and less of normal tissue complications. IMRT also has 
advantage over the conformal in terms of  choice of planning parameters such as 
beam direction. Further large fields and boosts can be integrated into the single 
treatment plan and also electrons can be  dispensed with permitting the use of  
same integrated boost plan for entire course of treatment
4,5
. The IMRT also offer 
added advantage like reducing the dose received by the normal tissue and at the 
same time higher dose per fraction can be delivered to the TARGET TISSUES.  
10 
 
There is also a clear cut advantage of  delivering high dose per fraction to the 
target tissues therby it can reduce the total number of fractions received by the  
patient therby reducing the overall treatment time , it also reduces the cost and 
burden of the treatment on the patient.  
IMRT also has a lot to offer from ART-adaptive radiotherapy .ART adaptive 
radiotherapy which means revision of the treatment plan by assessing the organ 
response and tumor response ,organ movement during the course of radiotherapy
6
.  
There are many trials which evaluated the feasibility and advantages of the 
adaptive radiotherapy  which included replan during the treatment course 
,taking cone beam CT images to assess the response of the nodal mass and also 
the target
7,8
 .  
Sequence of registration and adaptation: 
11 
 
 
Steps involved in treatment planning : 
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Limits and risks of  IMRT: 
Efficacy and the applocsbility of the IMRT  is also limited to in terms of 
dosimetric characteristics of dose delivery such as radiation scattering and also the 
transmission through the MLC leaves .   
In addition ; limited temporal and spatial coverage and overall accuracy of the 
IMRT dose verification systems will diminish the confidence in the delivered dose.  
 
 
 Comparison of Conforma3D CRTl (left) and IMRT (right). The ability of the 3D CRT to alter isodose lines was 
limited to shaping of field boundaries with MLCs or blocks, and the use of wedges or compensators for missing 
tissues and central blocks for shielding critical structures. The IMRT beams can have highly non-uniform beam 
intensities (fluences) and are capable of producing a more concave-shaped absorbed-dose distribution. With 
neither conformal therapy nor IMRT can the PRV be always completely avoided, but with IMRT the concave 
isodose curve that includes the PTV better avoids the PRV. The black region indicates the PTV; the gray region 
indicates a PRV, and the line surrounding the PTV is a typical isodose contour.
9 
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To illustrate the dosimetric advantage of IMRT over 3DCRT techniques, Figure 
below   shows the isodose curves for 4 different RT modalities:                        2 
plans of 3DCRT (with four and seven fields, respectively) and two IMRT 
plans, one using serial tomography and the second with a ten-field step-and-shoot 
MLC. 
 
 
 Typical isodose distributions for treating prostate cancer from (A) a four-field 
three-dimensional conformal radiation therapy (3DCRT) plan (4F-CRT), (B) a 
seven-field 3DCRT plan (7F-CRT), (C) an intensity-modulated radiation therapy 
plan delivered by serial tomotherapy using MIMiC (NOMOS Corp., Sewickley, 
PA), and (D) a ten-field step-and-shoot segmental multileaf collimator (SMLC) 
plan. 
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Fixed gantry IMRT: 
There are two steps involved .First a set of intensity profiles one for each incident 
beam is generated using  the dose optimization engine. Depending on the treatment 
planning , beam profile is modified  such that it may be continuous or discretised 
in space and intensity. One has to take into consideration that incident beam is 
already divided into grid of  beamlets  , each beamlet has its own intensity levels.  
Fixed gantry IMRT can be either MLC based delivery  or  a compensator based 
delivery.Most frequently used IMRT is the MLC based computer controlled one.  
Thus after the planning is done ; an intensity map is generated with a set of 
apertures using the MLC formed apertures by using an algorithm of leaf 
sequencing. These are recorded in the treatment planning systems , based on the 
movement of the MLC treatment is delivered. The treatment delivery can be either 
a step and shoot method or it can be a dynamic mode. In step and shoot method the 
MLC remains static and treatment is delivered i.e., dose only , motion only .In 
dynamic modes MLC moves along as the radiation beam moves i.e.,leaf movement 
and dose delivery  occurs simultaneously. 
6 
TERMINOLOGY USED  IN IMRT:
 
Monitor units:It is the dose which is delivered at the central axis of the treatment 
beam. In a linear accelerator the machinaes are calibrated such that their 1 MU is 
equivalent  to 1 cGy. 
15 
 
Beamlets: In view of intensity distribution optimization a IMRT beam is divided 
into a small intensity element which subdivide the intensity modulated beam. 
These are  called bixels or rays or pencil beams. It can be expressed in terms of 
16 
 
energy fluence or particle fluence based on dose calculation algorithm.
 
 Comparison between traditional (left) and IMRT (right) optimization processes. (Reprinted from J ICRU 2010: 
10(1). 
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Dynamic multileaf collimator: In this mode leaves move  continuosly which in 
turn shapes the incident beam when the radiation is turned on. In this way the 
treatment time can be shortened and also ensures high spatial resolution.
10,11 
Static multileaf collimator: SMLC:In this mode the leaves move only when the 
radiation beam is turned off . They remain in their pre determined positions and the 
radiation dose is delivered.   This is step and shoot technique.
12,13 
Segment: A basic unit of SMLC delivery which is a shaped aperture with a beam 
intensity which is uniform.  
Objective function: It is a clinical requirement of a mathematical formalism. It is 
of three types a)Dose based  b)Dose volume based  c)Dose response based  . 
A.Dose based—it is the minimum /maximum dose of a critical structures.  
B.Dose-Volume based—it is the fraction of the volume which can receive a certain 
dose. 
C.Dose-response based—it uses a clinical data to a dose requirement  which is 
limited into a clinical outcome. Normal tissue complication probability ,tissue 
complication probability and equivalent uniform doses which are certain clinical 
indicators.  
18 
 
Score: The key parameter for a IMRT optimization is SCORE. It’s a figure of 
merit –a objective function of  indicating the quality of treatment plan can be 
expressed in a numeric value.  
Forward planning: This is type of planning which is most commonly used in 
conformal treatment 3D CRT. This planning can be a trial and error process  such 
that the direction  of the beams and also the beam weights are modified acoording 
to the desired acceptable clinical solution. The forward planning system is also 
employed in planning the field in field technique.These field in field techniques are 
most commonly employed in breat, prostate , head and neck cancers.But still these 
approaches are still inferior to inverse planning techniques.
14,15,16,17 
Inverse planning: In this process the clinical requirements calculated from 
mathematic formalism is transferred into intensity patterns which are deliverable. 
Ehrgott et al has reviewed an article based on this mathematic formalism.  
Leaf sequencing and deliverable optimization: This consist of two steps .              
In the first step , there is generation of  ideal fluence pattern which can satisfy the 
optimum solution for objective function. In the second step ,  fluence  patterns 
which are ideal are delivered into the leaf sequences. A good optimization takes 
into account the constraints of the dose delivered and also the leaves characteristics 
so that it can reoptimize the leaf sequences in such a manner that it fulfills the 
19 
 
fluence distributions which are deliverable and also objective function is 
fulfilled.
18,19
  
Aperture based IMRT: In this the treatment portals are divided into a subset of 
predefined apertures/segments. Then the optimization process becomes a standard 
beam weight optimization. But this technique is inferior to the  inverse planning 
algorithm. 
20,21,22 
Multimodality image fusion: IMRT is very important in terms of target organ 
delineation , so using two or more imaging techniques and fusing them provides 
additional information about the treatment targets. In simple terms it can be 
explained that the two or more image sets of the the same subject are combined or 
fused into a single data set for better understanding of the structures involved.  
Image registration: The process by which the images are registered in 
correspondence with other image . 
DICOM: The most widely used image management and transmission protocol.  
DICOM  RT: It is an extension protocol of DICOM.  It  has  
RT structure set: Contours of the organs in the image set .  
RT image: DRR images-Digitally reconstructed radiographs. 
20 
 
RT plan:  Collimator  settings, Gantry angle , MU’s , MLC leaf position  and other 
treatment parameters.  
RT dose : Calculated dose . 
IMRT TREATMENT PLANNING: 
Delineation of  Target volumes: In ICRU 83 they have given certain guidelines 
for the treating volumes which forms the treatment plan. The contoured organs can 
be malignant tumor , normal tissue near the tumor, distant structures can be 
contoured. Based on the above structures the volumes are decribed below
23
. 
1.Gross tumor volume GTV:                                                                                        
It  is the macroscopic tumor volume which is demonstrable. 
GTV-T: Primary tumor. GTV-N: Metastatic regional node . GTV-M: Metastatic . 
2.Clinical target volume:CTV: 
It is the volume which encompasses the GTV along with microscopic disease 
around it or subclinical malignant tissues .Usually it is given as GTV plus 1cm  0r 
2 cm margin is given.  
3.Planning target volume: PTV:It is the volume in which margin was given to the 
CTV so that the absorbed dose is delivered to all the CTV parts with acceptable 
probability  inspite of differences in the setup variations and organ motion . 
21 
 
Organ at risk:OAR: 
These are the normal tissues /organs which are at the risk of  exposure to radiation 
while treating the tumor . Organ at risk if they receive a ceratin amount of radiation 
it results in a significant morbidity. This emphasis the importance of contouring the 
CTV and PTV with utmost care since the OARs can be exposed to the PTV /CTV 
doses which lead to morbidity of the patient. There are two types of  OARs serial 
organ and parallel organ. Serial organ are those in which point dose is calculated 
beyond which it may lead to unacceptable damage .e.g.,spinalcord. 
Parallel organs are those in which the dose is calculated according to the volume of  
tissue exposed  -they suffer a loss of  portion without loss of function.  
Planning organ at risk volume:PRV: 
In view of the differences in the organ motion and setup variations a margin has to 
be given to the organ at risk to avoid significant morbidity.  
Remaining volume at risk :RVR :Its the difference between volume enclosed by 
CTV’s and OAR’s and external contour of the patient. RVR is very much 
important withrespect to IMRT atleast in dose constraints. Without these volumes 
being contoured the dose optimization soft ware can produce a excellent dose 
distribution but with significant morbidity to the patient.  
22 
 
Treated volume:TV: 
The absorbed dose for the volume of tissue which comes under the isodose 
envelope which is prescribed by the radiation oncolocgist.The ICRU 83 proposes 
that the TV defined as the 98% of the PTV receiving the prescribed dose. So it can 
be DNEAR MINIMUM   and DNEAR MAXIMUM  .  
It should be taken into consideration that the PTV ,GTV,CTV are the volumes 
which are independent of particular radiation protocol employed. In IMRT 
treatment planning supplementary margins are given accordingly such that the 
variations in the organ motion and setup uncertainities are also to be taken into 
account. So the number of normal structure to be drawn also increases. The dose is 
escalated to unprecedented levels in IMRT the dose is at unprecedented levels 
,distribution of the dose is also highly non-uniform and the plans are generated 
,evaluated by computer optimization processs ,basically all the structures to which 
the dose needs to be constrained has to be contoured.  
IMRT TREATMENT PLANNING AND OPTIMIZATION: 
The main part of IMRT is the planning and optimization process. In this process 
the amount of dose to be administered and also the distribution of dose can be  
monitored. By changing the direction of the beams and also the fluence-by 
23 
 
changing the leaf position . By these processes the treatment is delivered according 
to the specific clinical problem into a machine delivereable beams. 
A.Fractionation and treatment schedule:  
IMRT plans are designed in line with conventional fractionation schedules. The 
doses can be delivered using 3D conformal methods followed by IMRT boost . 
IMRT plans are also done from the initial treatment in which larger fields are 
treated and also the boost fields are planned initially. 
24 
When target volumes in an IMRT plan are treated simultaneously it is the most 
conformal form of treatment. It can be thus said as SIB IMRT(Simultaneous 
integrated boost).SIB IMRT produces superior dose distribution, more 
efficient,less error prone in delivering the treatment because the same initial plan 
was followed till the end of treatment .
24,4,5.
  During the course of treatment there 
arise problem of matching the fields can be minimized.
25
In SIB IMRT the nominal 
dose and also the size of  fraction are corrected according to the  number of  IMRT 
fractions.  
The effect of acute and late toxicity of the oragn at risk /normal tissues should also 
be considered in case of modified fractionation schedule. Because of the increased 
conformality of the IMRT plan the dose received by the organ at risk are also very 
low when compared with  the conventional plans. 
24 
 
In the radiotherapy oncology group H-0022 study has evaluated the dosage 
fractions such as 2.2 Gy per fraction for 5 days x 6 weeks TD:66 Gy  to the PTV, 
2 Gy per fraction to high risk subclinical disease(nodal regions) TD:60 Gy , 1.8 Gy 
per fraction to the  subclinical disease TD:54 Gy given .All these corresponds to 
the biologically equivalent dose of 70,60 and 50 Gy. Also the dose constraints for 
the organ at risk are brain stem -54 Gy , Spinalcord-45 Gy , Mandible-70 Gy. The 
mean dose of the parotid glands should also be kept below 26 Gy or 50 % of one 
parotids should be well kept below 30 Gy. When compared with the conventional 
2 D ,3 D planning techniques the dose received by the parotids in IMRT is very 
less which in turn significantly affects the post treatment morbidity in patients . 
Treatment associated development of xerostomia reduced significantly with 
improved treatment techniques. 
26
 
 The SIB strategy at Virginia Commonwealth University study the  dose-escalation 
protocol ,the  primary nominal dose  are  68.1, 70.8, and 73.8 Gy, in 30 fractions  
which are biologically equivalent to 74, 79, and 85 Gy , if given in 2 Gy per 
fraction  are used.
27
 Also the subclinical disease (nodes )  prescribed  are                   
60 and 54 Gy, respectively  which are biologically equivalent to 60Gy and  50 Gy, 
respectively,  given in 2 Gy fractions. Spinal cord-45 Gy  and brainstem-55 Gy  
respectively .  
25 
 
In Mallinckrodt institute of radiology , Simultaneous integrated boost  strategy for 
definitive IMRT TD:70 Gy in 35 Fractions in 2 Gy per fraction to the gross disease 
The soft tissue at risk and nodal areas at high risk received TD:63 Gy in 1.8 Gy per 
fraction ,the elective nodal regions received TD:56 Gy  in 1.6 Gy per fraction .
28 
In a study by Mendenhall et al. altered dosage fractionations are described 
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B.Beam configuration: 
Optimisation of a beam angle is very much important in IMRT plan so that there is 
a greater control of  beam on dose distributions .However  greater control of beam 
angles may find path which is least obstructed by critical structures. The number of 
beams used and number of combinations which are compared  are  some of the 
advances in the mathematical research . For eg., for a three beam combination 
atleast 60,000 beam combinations are compared, for a five beam nearly 14 million 
combinations are tested,for seven beam nearly 1.5 billion combinations are 
tested.
30-33.
 In general if there is an  increase in the number of beams there is an 
opportunity to get a desired dose distribution very easily. But in practical ,in case 
of fixed gantry beam IMRT , it is always advisable to reduce the number of beams 
to reduce the treatment time and also the effort required to put in the dosimetric 
verification, delivery of treatment, Quality assurance, planning.  In his study Webb 
et al. has emphasized that 7 to 9 treatment beams are itself necessary to produce  
highly conformal and adequate dose distribution. 
34 
The most advantage of placing 
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the beams is in the directions such that they are not opposing each other .  most 
often beams are constrained to lie in the transverse plane. In general the beam 
configurations used for 3 D conformal are not optimal for IMRT.
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C. Systems using rotating slit approach:  
1.Tomotherapy delivery
36 
2.Peacock system 
37 
PLANNING OBJECTIVES: 
Optimization engines help in optimization of ray intensities by several methods 
with its own strengths and weakness  depending on the nature of objective function 
and individual prefernce. The basic principle is that each ray of each beam that 
passess through the target volume is traced from the source of radiation through the 
patient 
70.
 . Each patients 3D image is divided into VOXELS. Every voxel has a 
dose in the patients body which is calculated for the initial set of rays. The score of 
the treatment plan is calculated from this resulting dose distribution. The ray 
tracing process identifies the tumor and also traces it down to the normal tissues 
that along the path of the ray. By changing the weight of the ray , score is 
calculated. If the weight of the score is increased which leads to favourable 
consequences for that patient then the weight is increased and vice versa. With 
each and every change in the weight of the beam the treatment optimization 
improves . Only a few changes in ray weight is is permitted at a time.    
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Objective functions: 
Dose based :  
It can be explained as sum of the squares of differences in dose and computed dose 
in each point within an each volume of interest. This is called as quadratic or  
variance objective function. The main fuction of the optimization process is to 
bring down the value of   S .  
 
DT,O- Target volume receiveing the desired dose.  
Dn,o-n th normal structures tolerance dose. 
DT,i-I th voxel of the targets computed dose.  
Dn,j-j th voxel of the n th normal structures computed dose.  
Pn- the relative penalty for for exceeding the tolerance dose.  
The voxel does not contribute to the score function if the dose in normal tissue not 
exceeding the tolerance limit.  
For the normal organs , H (Dn,j – Dn,0) is a step function defined as follows: 
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Dose--volume based : Advantages: 
Both the normal tissue and the tumor mass responds to the radiation which can be 
explained by the amount of radiation each of it has received which is most 
commonly expressed in volume. The dose volume based objective function is most 
widely used and it also explains the volume of the structure  which can receive a 
particular limit of dose. It is mandatory as explained in ICRU-83 that the doses 
received by the structures should always be expressed in terms of  DVH dose 
volume histograms and  dose volume criteria. In his study Bortfeld et al.
110 
 the 
objective are laid for dose volume histograms. Two points are taken into 
consideration D1 & D2. The  volume receiving more than D1 has a volume which 
is less than V1. So it is necessary that this constraint needs to be implemented 
depend on the another dose value D2. So that in the current DVH data V(D2) = 
V1. The objective function of the organ at risk can be given as : 
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 A method of incorporating dose–volume constraints in IMRT optimization. 
(Adapted from Wu Q, Mohan R. Algorithms and functionality of an intensity 
modulated radiation therapy optimization system. Med Phys 2002;27:701–711. 
 
So to limit the hot  and cold spots , there should be  two dose volume criteria needs 
to be specified. So while prescribing the data for desired dose of 80 Gy. We 
specify that volume receiving  >85 Gy should be less than 5 % and  volume  
receiving  >79 Gy should be >95% .so thus for objective optimization of the 
technique a dose volume criteria is more flexible and have a greater control over 
the dose distributions.  
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Limitations of  Dose volume histogram: 
 
One limitation of the dose–volume histogram (DVH) prescription: one DVH 
control point (at 50 Gy and 25% of the volume) can have multiple DVH  lines of 
inequitable clinical implications. 
 
To illustrate one such limitation, consider the example of a normal structure the 
constaraint has been  not more that 25% of the volume  to receive 50 Gy or 
higher. All the above  dose–volume histograms meet this criteria. However, the 
DVH represented by the solid curve clearly causes the least damage. In order to  
overcome this limitation by specifying multiple dose–volume constraints or even 
the entire DVH it  would be too limiting. Multiple DVHs could lead to similar 
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levels of injury to a particular organ, but each DVH may produce a different 
effect on other organs and the tumor. When this happens, DVHs usually cross 
each other, as shown. Only one of them is optimum so far as the tumor and other 
organs are concerned. So the ICRU has come up with the terms such as  
 
NTCP-Normal tissue complication probability. 
TCP- Tumor control probability. 
EUD-Equivalent uniform dose.  
D.RATIONALE BEHIND THIS STUDY: 
Concurrent chemoradiation is an essential component of treatment in locally 
advanced head and neck cancers .The treatment in unresectable head and neck 
cancers is concurrent chemoradiation. Techniques of RT varies from conventional 
to that of IMRT . Some of the most common side-effects are Mucositis ,dysphagia 
and late side effect xerostomia  in patients with head and neck cancers. Among 
them Xerostomia which is late complication of RT causes difficulty in speech, 
difficulty in swallowing leading to impairment of QOL .In the treatment for head 
and neck cancers there are instances in which there is incidental high dose 
radiation to the Organ at risk (OAR) such as parotid glands,resulting in long term 
xerostomia is a well-recognized problem after radiation therapy for head and neck 
cancers. These affect the quality of life of a patient during his post treatment follow 
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up.QOL after RT is largely related to xerostomia in survivors. Recent 
technological advances have led to the successful clinical use of intensity-
modulated RT (IMRT).IMRT helps in decreasing the number of patients who 
develop xerostomia , at the same time by sparing organ at risk , without 
compromising tumor control in head and neck patients.  However, large variations 
can be observed during the course of  IMRT treatment, such as body weight loss 
and primary tumor shrinking . Due to these anatomical variations and to the tight 
IMRT dose gradient, the actual administered dose may therefore not correspond to 
the planned dose, with a risk of radiation overdose to the parrotid gland. This dose 
difference clearly reduces the expected clinical benefits of IMRT, increasing the 
risk of  xerostomia.So there is a need to determine the indications for adaptive 
radiotherapy. To evaluate the predictors of xerostomia in patients with head and 
neck cancers treated with IMRT, we compared dosimetric parameters of the 
parotid glands with the grade of xerostomia. 
        As many studies indicated that in patients with locally advanced head and neck 
cancers treated with IMRT, there is erroneous distribution of dose to the Organ at 
risk (OAR) such as parotid, pharyngeal constrictors, submandibular glands.  ART 
(adaptive radiotherapy) replanning (remould and repeat CT planning)  
during the course of radiation treatment aims to decrease the radiation 
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overdosage to the organ at risk significantly. In this study we aim to calculate 
the dose received by the ipsilateral parotid and also the contralateral parotid . 
        In our study the mean dose received by the parotid gland , during the start of 
treatment and later at 40 Gy (20
th
 fraction) were compared.However we need some 
prospective studies which aim to assess the dose received by the OAR.Main aim 
was to detect the differences in planned dose delivered to the organ and the actual 
dose received by the organ. Thus it also helps in finding out dose differences with 
replanning at 40 Gy and without replanning at 40 Gy. This finds out the advantage 
of adaptive radiotherapy.  In this study we planned to take a CBCT image of the 
patient at 40 Gy  in the varian system –treatment delivering room. The physicit has 
calibrated the  CBCT  images in such a way that the images are comparable to the 
CT planning images taken before the start of the treatment.  Thus  the  CBCT 
image taken is transfered to the TPS planning syatem using the DICOM server . 
The images are imported and are super imposed onto the initial CT plan . The 
organ at risk and the GTV,CTV and PTV are contoured. These images are then  
superimposed on the initial planning CT . The dose to the PTV and organ at risk 
are calculated.  We do this study to estimate/quantify the level of errors that 
would be introduced if  we don't do adaptive replanning based on patient's 
morphological changes  .   
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        CONE BEAM CT: 
        Cone beam CT images are different from that of the normal routine CT images. 
The cone beam CT images are volumetric images . The cone beam CT 
incorporated into the VARIAN has a quality which can match that of the normal 
routine CT images . The volumetric images are then reconstructed into 2 D images. 
These 2D images have lesser resolution quality and also the image quality is 
relatively less . Thus also takes lesser time to acquire the 3D volume information. 
It carries on board imaging advantage. It is also very much cost effective when 
compared with replanning CT .  The quality of the Cone beam CT images are to be 
calibrated by the physics team in such a way they are equivalent to the CT images. 
The physics team makes sure that the Elecrton density curve of the CBCT 
(calibrated) to near match with the electron density curve of the  CT 
E.ANATOMY : 
The word throat is used for the parts of the neck anterior to the vertebral column, 
especially the pharynx and the larynx.  
The pharynx is the part of the digestive system situated posterior to the nasal and 
oral cavities and posterior to the larynx. 
 It is therefore divisible into nasal, oral, and laryngeal parts:  
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(1) nasopharynx, (2) oropharynx, and (3) laryngopharynx.                                    
The extension of the pharynx is from the base of the skull to the inferior border 
of the cricoid cartilage (around the C6 vertebral level), below which it is 
continuous with the esophagus.   
Superiorly there is the sphenoid and occipital bones , whereas the prevertebral 
fascia and muscles as well as the upper six cervical vertebrae,posteriorly.  
The pharynx is a fibromuscular tube and is lined by mucous membrane. 
The pharynx is the common channel for both deglutition (swallowing) and     
respiration, where the food and air pathways cross each other. During anesthesia,  
the  extension of the neck facilitates the passage of air through the pharynx. 
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Subdivisions: 
Nasopharynx:  
The nasopharynx in its small anterior portion, continues as the posterior portion of 
the nasal cavity and functions as part of the respiratory system. 
The nasopharynx communicates with the oropharynx through the pharyngeal 
isthmus, which is bounded by the soft palate, the palatopharyngeal arches, and the 
posterior wall of the pharynx.  
The isthmus is closed by muscular action during swallowing. 
The junction between nasopharynx and the nasal cavity proper is the choanae.   
The (naso)pharyngeal tonsil is a mass of lymphoid tissue embedded in the mucous 
membrane of the posterior wall of the nasopharynx. 
Enlarged (naso)pharyngeal tonsils are termed ‘adenoids’ and may cause respiratory 
obstruction.A minute pharyngeal hypophysis (resembling the adenohypophysis) is 
present high up. 
Each lateral wall of the nasopharynx has the pharyngeal opening of the auditory 
tube, located about 1 to 1.5 cm  
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(1) inferior to the roof of the pharynx, 
 (2) anterior to the posterior wall of the pharynx 
(3) superior to the level of the palate 
 (4) posterior to the inferior nasal concha and the nasal septum . 
An opening like a nostril is present on the auditory tube . 
Superiorly by a tubal elevation(tubal torus),through which the auditory tube can be 
catherised. 
Mucosal folds extend from this area of the auditory tube to the palate and the side 
walls of the pharynx. 
The pharyngeal recess is the part posterior to this tubal elevation and the lymphoid 
tissue near it is reffered to as the tubal tonsil. 
Infections can easily spread from the pharynx to the auditory tube as it is 
‘pharyngotympanic’. 
This tube equalizes the pressure of the external air and that in the tympanic cavity.   
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Oropharynx: 
The oropharynx extends inferiorly from the soft palate to the superior border of the 
epiglottis. It communicates  
Anteriorly: faucial (oropharyngeal) isthmus,  
Superiorly :  soft palate . 
Laterally: palatoglossal arches 
Inferiorly: tongue. 
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This area is characterized by a lymphatic ring composed of the nasopharyngeal, 
tubal, palatine, and lingual tonsils. 
 
The mucous membrane of the epiglottis is reflected onto the base of the tongue 
and onto the lateral wall of the pharynx.The space on each side of the median 
glosso-epiglottic fold is termed the epiglottic vallecula. 
Each lateral wall of the oropharynx has the diverging palatoglossal and 
palatopharyngeal arches, which are produced by the similarly named muscles and 
are often called the anterior and posterior pillars of the fauces, respectively. The 
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triangular recess (tonsillar fossa) between the two arches lodges the palatine tonsil, 
which is often referred to as merely ‘the tonsil’. (A tonsil is a mass of lymphoid 
tissue containing reaction or germinal centers and related to an epithelial surface in 
the pharynx.) The medial surface of the tonsil usually has an intratonsillar cleft 
(commonly but inaccurately called the "supratonsillar fossa") and a number of 
crypts. The lateral surface is covered by a fibrous capsule and is related to fascia, 
the paratonsillar vein (the chief source of hemorrhage after tonsillectomy), and 
pharyngeal musculature. The tonsil is supplied by the tonsillar branch of the facial 
artery, and it drains into the facial vein. Involution of the tonsil begins at puberty 
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Hypopharynx: 
Hypopharynx projects laterally on each side of the larynx.  
The three main parts of hypopharynx are  
1)Postcricoid region 
2)Posterior Pharyngeal wall 
3) Two Pyriform sinus. 
It lies at the level of 3
rd
 to 6
th
 cervical vertebra. 
Superiorly: Tip of epiglottis 
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Inferiorly: lower border of cricoid cartilage. 
1)PYRIFORM SINUS: 
It is an inverted shaped pyramid. 
       Extent: -Superiorly: epiglottis . 
       Lateral: thyroid cartilage  
       Medial: arytenoid cartilage; aryepiglottic fold. 
        Posteriorly: open & continuous with posterior pharyngeal wall.  
        Apex: meeting of anterior, lateral &medial wall inferiorly 
       2)POST CRICOID REGION  
       Pharynx continues with the eosophagus at the post cricoid region. 
       Extent : 
       Superiorly:Aretenoids and inferiorly by the esophagus. 
3)POSTERIOR PHARYNGEAL WALL 
covers the middle and inferior constrictor muscle 
separated from pre vertebral fascia by the retropharyngeal space. 
Extent: Superiorly: upper border of epiglottis  
Inferiorly: lower border of cricoid  
Sideways: apex of one pyriform sinus to other. 
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Nerve supply of hypopharynx 
Internal branch of superior Laryngeal nerve :vagus(X) 
Glossopharyngeal nerve :(IX)  
sensory: External branch of superior Laryngeal nerve (X) Recurrent laryngeal 
nerve (X) Pharyngeal plexus (IX) motor 
LYMPHATIC DRAINAGE  
Deep cervical lymph node : level 2,3& 4  
Prelaryngeal&paratracheal lymph nodes: level 6.  
Retropharyngeal node -Node of rounviere at base of skull. 
CARCINOMA HYPOPHARYNX  
Constitute 5.2% of upper aerodigestive tract cancer.  
Mostly squamous cell carcinoma. 
Mean age of presentation 65 years  
Common stage of presentation : stage III& IV -POOR PROGNOSIS 
INCIDENCE OF HYPOPHARYNX CARCINOMA. 
65-75%-pyriform sinus carcinoma 
5-15% - post cricoid carcinoma. 
10-20% -posterior pharyngeal carcinoma. 
RISK FACTORS IN CARCINOMAHYPOPHARYNX  
Age & Sex: carcinoma pyriform fossa- male > 40 years  
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Carcinoma postcricoid region: females 20 to 40 years  
Carcinoma posterior pharyngealwall : males above 50 years  
Personal history -Tobacco ,Alcohol 
Exposure :polyaromatic compounds ; asbestos & welding fumes  
Nutritional deficiency. Vitamin A& E. iron, Carotenoids and flavenoids. 
RISK FACTORS OF CARCINOMA HYPOPHARYNX : 
Infections; HPV (20–25% only postive for HPV DNA&Ab against HPV 16 E6 & 
E7)  
Associated diseases: PLUMMER VINSON SYNDROME  
GENETIC: P53 & EGFR mutation -Synchronous &metachronous malignancy. 
FIELD CANCERIZATION : 
Hypopharyngeal carcinoma occur within the field of diseased mucosa.Carcinogens 
induce dysplastic changes in mucosa of the upper aero digestive tract which 
increases the risk of malignancy. 
CARCINOMA OF PYRIFORM SINUS : 
Age:40 years  
presentation: late; Metastatic neck nodes  
Local Spread:Upwards- base of tongue – Downwards: post cricoid region- 
Medially:AE fold and ventricles-  Laterally: thyroid cartilage 
Lymphatic spread: upper and middle group of jugular cervical nodes – 
45 
 
Distant metastasis: occur late and may be seen in lung, liver, bone 
CARCINOMA OF POST CRICOID REGION : 
Plummer-Vinson syndrome age group of 20-40; female Progressive dysphagia 
Voice change Weight loss  
Spread: local spread - cervical oesophagus, arytenoids  
Lymphatic spread - paratracheal nodes, may be bilateral due to midline nature of 
lesion 
CARCINOMA OF POSTERIOR PHARYNGEAL WALL : 
Mostly seen in males above 50 years of age  
Clinical features: dysphagia, metastatic neck node  
Spread: local - prevertebral fascia, muscles and vertebrae  
Lymphatic: usually bilateral, retropharyngeal and deep cervical nodes involved 
CLINICAL PRESENTATION  : 
Hoarseness of voice: vocal cord fixation  
Stridor: mass effect on trachea  
Weight loss, Anemia, malnutrition, Throat pain, Sore throat,dysphagia 
Odynophagia ,pooling of saliva  
Referred otalgia: cause int. laryngeal nerve (X) Neck mass: metastatic neck node 
Direct extension :most frequent presenting symptoms include a neck mass (either 
representing the tumour or nodal metastases . 
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ANATOMY OF HYPHOPHARYNX 
 
STAGING OF HYPOPHARYNGEAL CANCER 
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Anatomy of  PAROTID GLAND: 
The parotid gland is the largest of the three salivary glands. 
Weighs around 14 to 28 gm. 
It lies upon the side of the face, immediately below and in front of the external ear.  
The main portion of the gland is superficial, somewhat flattened and quadrilateral 
in form. 
It is placed between the ramus of the mandible in front and the mastoid process and 
Sternocleidomastoideus behind, overlapping, however, both boundaries.  
Above, it is broad and reaches nearly to the zygomatic arch; 
Below, it tapers somewhat to aboutthe level of a line joining the tip of the mastoid 
process to the angle of the mandible.  
The remainder of the gland is irregularly wedge-shaped, and extends deeply 
inward toward the pharyngeal wall. 
The gland is enclosed within a capsule continuous with the deep cervical fascia; 
the layer covering the superficial surface is dense and closely adherent to the 
gland; a portion of the fascia, attached to the styloid process and the angle of the 
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mandible, is thickened to form the stylomandibular ligament which intervenes 
between the parotid and submaxillary glands.  
The parotid duct (ductus parotideus; Stensen’s duct) is about 7 cm. long. 
 It begins by numerous branches from the anterior part of the gland, crosses the 
Masseter, and at the anterior border of this muscle turns inward nearly at a right 
angle, passes through the corpus adiposum of the cheek and pierces the Buccinator; 
it then runs for a short distance obliquely forward between the Buccinator and 
mucous membrane of the mouth, and opens upon the oral surface of the cheek by a 
small orifice, opposite the second upper molar tooth. While crossing the Masseter, 
it receives the duct of the accessory portion; in this position it lies between the 
branches of the facial nerve; the accessory part of the gland and the transverse 
facial artery are above it 
Structure.—The parotid duct is dense, its wall being of considerable thickness; its 
canal is about the size of a crow-quill, but at its orifice on the oral surface of the 
cheek its lumen is greatly reduced in size. It consists of a thick external fibrous 
coat which contains contractile fibers, and of an internal or mucous coat lined with 
short columnar epithelium 
Right parotid-Posterior and deep aspects 
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 Right parotid gland. Deep and anterior aspects 
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HISTOLOGY: 
The gland has a capsule of its own of dense connective tissue, but is also provided 
with a false capsule by investing layer of deep cervical fascia.  
Parotid gland is the largest, it provides 25% of the total salivary volume. The 
serous cell predominates in the parotid, making the gland secrete a mainly serous 
secretory product. 
 
The parotid gland also secretes salivary alpha-amylase (sAA), which is the first 
step in the decomposition of starches during mastication. It is the main exocrine 
gland to secrete this. It breaks down amylose (straight chain starch) and 
amylopectin (branched starch) by hydrolyzing alpha 1,4 bonds. Additionally, the 
alpha amylase has been suggested to prevent bacterial attachment to oral surfaces 
and to enable bacterial clearance from the mouth.
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CLINICAL EVALUATION  
History of  illness 
General examination  
Oral hygiene and dentition  
Airways 
History of   voice change  & difficulty. 
Examination of oral cavity , oropharynx.  
Examinaton of neck nodes. 
Indirect layngoscopy 
Direct laryngoscopy 
EXAMINATION OF NECK NODES  
Location ,Size,number ,Mobility ,Tenderness ,Relationship with adjacent structure. 
Examination of neck nodes: sub mental(Ia) ,submandibular(Ib),upper.,middle& 
lower deep cervical (ii; iii. iv) 
INDIRECT LARYNGOSCOPY –mirror is warmed; -Hold tongue with gauze -
Introduce mirror into the oral cavity facing downward - mirror brought to rest 
against the uvula -do not touch the posterior pharyngeal wall - laryngeal inlet is 
visualized. 
Structures seen on indirect laryngoscopy (in order):  
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Base of the tongue ,Vallecula,Median and lateral glossoepiglottic folds 
Epiglottis ,Vestibular fold ,True vocal cords ,Trachea ,Layngeal cartilage 
 
PRE TREATMENT EVALUATION:  
a.To asses extent of tumor Relation with other structure  
b.Mobility of vocal cords  
c.Direct laryngoscopy  
d.Oesophagoscopy 
e.Chest xray :infection; malignancy;metastasis 
f.HRCT : thickness, invasion, L.N metastasis  
g.MRI :soft tissue details, tissue edema  
h.PET :residual or recurrent tumor after RT. 
f.REVIEW OF LITERATURE: 
Several studies have investigated setup uncertainty in HNC patients which could 
change the dose distribution to the target volume and OARs.
38 
An inappropriate 
definition of the CTV ,PTV margin, accounting for organ motion and setup 
errors,may yield an under dose to the CTV. 
ART(adapative radiotherapy) planning can be initiated to minimize uncertainties 
for patients with a great reduction of the circumference or thickness at the level of 
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mastoidtip at the 20
th
 fraction of RT. Generally most of the patients had a reduction 
in body mass factors (BMF’S) with time.39 
All patients were positioned supine in an individualized thermoplastic head and 
neck mask for CT simulation and treatment. This leads to targetunderdosing and 
overdosing of nearby OARs(organ at risk ), whereas overcompensation for 
uncertainities leads to unnecessary irradiation of normal tissue and constraints in 
treatment planning. 
So the ratio between tumor control probability( TCP) and normal tissue 
complication probability (NTCP) emphasizes the role of minimizing uncertainties 
to enhance the therapeutic ratio of radiation. 
Daily online image guidance helps in correcting these setup uncertainities .For 
patients with anatomic changes due to tumor shrinkage or 
weightlossadaptiveradiotherapy is considered.But increased costs, higher staff 
workload ,and radiation doses to OAR(organ at risk ) of the patients should also be 
considered. So is the need to evaluate suitable indications for adaptive radiotherapy 
in head  and neck cancers.CBCT(cone beam CT) images are taken at 20Gy and 
40Gy.Organ at risk (OAR) like spinalcord ,brainstem, parotidgland 
,submandibulargland,mandible are contoured by the same radiation oncologist on 
the CBCT(cone beam CT) images and deformed to the initial planning CT.DVH 
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generated for this structures from initial clinical plan was evaluated ,NTCP and 
TCP were calculated. 
One plausible factor is that the shrinkage of soft tissue after RT leads to errors in 
immobilization.
48
So as a result therewill be erroneous distribution of dose to the 
OARS.In order to overcome this,CBCT images are taken at 20 Gy and 
40Gy,during which the differences are maximum.OARs are contoured in CBCT 
images and registered on planning CT,to evaluate the NTCP for OARsmainly 
parotids.Thus the consistency between setup errors for the bony structure and the 
target could be established.CBCT images were calibrated and the electron density 
curve is matched close to the fan beam CT (Planning CT’s electron density curve 
to ensure minimal deviation in dose calculation.Replans were calculated on the 
acquired CBCT images. There was a significant reduction in gross tumor volume 
at the 20
th
 fraction of radiation/40 Gy ,this in turn reflects in the volume of the 
planning target . In our study , organ at risk especially the parotids are significantly 
away from the planning target i.e., away from the planning target volume .  
If the same initial plan is continued till 40 Gy ,the parotids which are well away 
from the planning target volume tends to move into the treatment field thereby it 
receives dose more than that which is planned leading to xerostomia which 
significantly causes dryness of mouth ,dysphagia . This in turn reflects the 
morbidity of  the patient.  
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II.OBJECTIVE OF STUDY: 
a)AIM OF THE STUDY: 
• To analyse the impact of  adaptive radiotherapy on organ at risk at 40 Gy  
before radiotherapy and changes occurring during radiation leading to 
erroneous dose distribution to normal tissues ,organ at risk in patient with 
head and neck cancers and need of replanning at 40 Gy. To evaluate the dose 
volume histogram datas in patients diagnosed as stage III/IV cancer in the 
Nasopharynx/Oropharynx/Hypopharynx. 
• All patients are treated with IMRT using planning CT images and evaluated 
with CBCT images during the course of treatment.  
b.Primary objective: 
This is a prospective study done in our institute between March 2017 to August 
2017.  To evaluate whether organ at risk OAR receive higher doses compared to 
that of planned dosage due to anatomical variation.  . 
Secondary objective:  
1.TCP/NTCP ratio calculation . 
2.Change in Body mass factors and need for replanning. 
3.Impact of replanning .      
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So in this study we have to do treatment planning and delineate target and normal 
structures.Then we have to do Image guidance and treatment verification using 
electronic portal imaging device which corrects using matching of bony anatomy 
and reference markers.At 40 Gyreplanning is done in CBCT , OAR  ,GTV , CTV 
,PTV are contoured and superimposed on initial planning CT images to calculate 
the TCP/NTCP of OAR. 
Methodology: 
STUDY DESIGN:PROSPECTIVE STUDY. 
STUDY PERIOD:MARCH2017-AUGUST 2017 
No. of patients : 30. 
ELIGIBILITY CRITERIA: 
Inclusion criteria:   
All patients with  
1. Age >30 years.  
2. Both sexes  
3. Sites included-Nasopharynx,oropharynx,hypopharynx .(stage II/III) 
4. Patients planned for definitive Chemoradiation/definitive radiation.  
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5. ECOG performance status-0/1 
Exclusion criteria:  
1. Poor performance status. (PS 2 or above) 
2. Preiously treated or treated outside initially. 
3. Upfront surgery.  
4. Palliative intent treatment/Metastatic disease . 
c.Methods and Materials:    
Methods of Planning:  
1.Patients are immobilised with thermoplastic mask.  
2.CT for RT planning done from Orbit to shoulder with 3mm cuts  
3.Marks like leadshot are placed at 3 places in same line over patients surface 
using laser to facilitate accurate daily position.   
4.For patients receiving definitive radiation CTV was defined as GTV+1-1.5cm 
margin.Guidelines for delineation of elective nodal CTV were followed.PTV was 
extended 3mm around CTV.  
5.IMRT plans are generated.  
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6.Prescription dose will be 54 Gy to CTV and boost to high risk regions primary 
and involved lymph nodes upto a Total dose of 66 Gy.  
Method of Treatment verification:  
1.Patients are positioned on the couch according to reference marks already kept 
during planning.  
2.Online On board imaging (2D KVCT daily and 3D CBCT at                      10 th 
and 20 th fraction were taken and registered with Digitally reconstructed 
radiographs from the treatment planning images.  
3.Images are compared by correlation of bony anatomy and differences are 
corrected by shifting couch translationally before treatment.  
4.Atleast 3 reference landmarks included-3 visible bony landmarks:  
1.Vertebra of Cervical Spine.2.Nasal septum.3.Mandible profile.  
5.In CBCT OAR image structures are outlined and registered with the planning 
CT.Registered structures are evaluated for dose delivered by clinical plan.  
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III.RESULTS AND ANALYSIS: 
1.NTCP of parotids: 
 
    The box plot analysis explains the probability of the normal tissue complication 
probability of parotids without replanning at 40 Gy. There was an apparent 
increase in the dose received by the parotids if the same initial plan is continued till 
60 Gy. The p value in our study is about <.0001 , which is statistically significant. 
These statistically significant values also transformed to give us practically 
significant results. 
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 So from this we can infer that replanning at 40 Gy will reduce the dose received 
by the parotids and thereby reducing the normal tissue complication 
probability.   This means that the mean parotid  dose received is only around 28-30 
Gy for both the parotids. So this is very much in favor of the study which aims to 
reduce the morbidity and also the longterm complication such as xerostomia which 
can be prevented in our patients by adaptive replanning at 40 Gy .  
B.Planning target volume: 
The planned target volume comparison between the initial planning and the 
replanning CBCT(cone beam CT ) structure sets also showed that there was a 
significant reduction in the volume of the gross tumor volume. From this we can 
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infer that at 20 th fraction of the radiation regimen there was a significant reduction 
in the planning target volume which if taken into consideration during replanning 
can reduce the normal tissue complication . The box plot curve of the planning 
target volume (PTV)  shows a significant reduction in the volume of the planned 
target which is prescribed to get a V95%  dose.  
 
When the initial planning target volume was compared with the replanning  target 
volume the values are statistically significant with the p value of  >.0001.This 
variable also supports this study whereby the effect of replanning at 40 Gy can 
bring about significant change/reduction in the morbidity of the patient. 
Paired Samples Correlations 
 N Correlation Sig. 
Pair 1 PTV2 VOL CC & PTV1 VOL CC 30 .752 .000 
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C.PTV V95% dosage: 
 The V95%  is that volume of the planned target volume receiving 95% of the dose 
prescribed.There was no significant difference in the paired T test compared  with 
the initial PTV V95%. 
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So this analysis shows that eventhough there is a change in the gross tumor volume 
, the dose which has to be received by the planned target volume is not 
compromised , which in turn reflects the study in a positive way. 
The above bar diagram also indicates that the PTV V95 %  for the initial planning 
CT was 97.43 % . The PTV V95% for the replanning CT is about 97.1 % . Thus 
there is not much of a difference in the dose received by the target.  
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Thus from this we infer that without compromising the dose received by the 
planned target volume we are able to spare the parotid glands thereby reducing the 
normal tissue complication probability.  
 
 Mean Std. Deviation N 
PTV2 V95 97.0980 1.46420 30 
PTV1 V95 97.4317 1.33127 30 
 
D.Dose distribution at 40 Gy: 
The below picture clearly depicts that during replanning at 40 Gy the dose 
distribution to the parotids show a significant change when compared with  initial 
planning target volume. Also the volume of the gross tumor also shows a 
significant decrease in the volume so the shrinkage of the tumor and also other 
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body mass factors related with it shows that if the same initial plan is followed the 
parotids will also get the target /prescribed dose leading to increase in the dose 
received by the normal tissues leading to unplanned normal tissue complication.
Dose distribution at 40 Gy
 
E.Dose volume histogram of parotids: 
The below dose volume histogram of the parotids shows the DVH of the initial 
parotids with that of  the DVH of  the replanning CBCT image taken at 40 Gy. So 
from this graph it is evident that there is a significant increase in the dose received 
by the parotids if the same initial clinical plan is continued till 60 Gy. The blue line 
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denotes the initial planning CT with DVH of parotid ,the red dotted line denotes 
the DVH of parotids for replanning CBCT images at 40 Gy.
DVH of Parotid
 
Thus the dose volume histogram depicts a clear advantage in favour of replanning 
CT at 40 Gy .  
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F.Dose volume histogram of  PTV: 
DVH of PTV
The dose volume histogram of the PTV – initial dose compared with the 
replanning PTV dose . From the above we infer that the dose received by the 
planned target volume always receives the maximum prescribed dose , so thereby 
it helps in achieving the planned dose and also at the same time helps in reducing 
the dose received by the parotids. Parotids being the major salivary gland ,sparing 
it will help reducing the late complications such as xerostomia , difficulty in 
swallowing. 
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G.Fusion of CT with CBCT image:  
 The above image shows the initial planning CT images are fused with the Cone 
beam CT images (CBCT)  so that we can evaluate the percentage of normal tissue 
receiving the dose higher than the initial plan. The parotids which are away from 
the planning target volume in the initial CT have very well moved into the 
treatment field thereby receiving the planned target dose which in turn increases 
the mean volume of the parotids . 
Image showing parotid sinking into 
field 
 
The sinking of the parotids into the PTV results in increased dose to the parotids 
leading to xerostomia.  
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The following table is data analysis obtained from this study: 
S NO 
PAROTID  
REPLAN 
PAROTID  
INITIAL 
PTV2  
V95 
PTV2  
VOL CC 
PTV1  
V95 
PTV1  
VOL CC 
CORD GY  
INITIAL 
CORD GY  
REPLAN 
NTCP  
CT 
NTCP  
CBCT 
1 1.75 18.55 99.5 768 97.55 1099 33.55 10.99 0.0000015 0.062 
2 4.5 28.46 96.6 687 98 1078 30.75 13.4 0.019 5.67 
3 4.63 18.24 98.64 687 97.8 1008 27.56 15.28 0.11 27.17 
4 5.65 19.9 97 599 98 1126 35.9 8.83 0.13 28.03 
5 5.66 17.55 98 611 97.5 910 30.65 10.35 0.14 13.58 
6 6.5 27.2 95 650 96.5 989 28.65 12.5 0.17 20.21 
7 6.86 27.66 99.99 650.2 99.06 1113.4 35.99 9 0.19 29.58 
8 7 20.65 95 1001 93.23 1301 34.82 10.5 0.2 16.24 
9 10.05 26.8 95.56 650 98.06 1075 33.06 9.86 0.21 19.86 
10 10.41 24.48 95 991 95.56 1331 32.82 12.5 0.22 16.86 
11 10.45 18.8 95 550 97.5 995 29.56 11.02 0.22 27.87 
12 10.5 22.38 96 698 96 1086 27.65 10.92 0.23 24.45 
13 10.52 25.06 96 439 98.5 977 29.08 14.54 0.23 28.88 
14 10.55 17.66 97 596 98.5 1176 38.22 8.98 0.23 28.15 
15 10.96 15.9 97.55 550 99.01 979 34.32 7.55 0.24 25 
16 11.55 23.56 98 750 97 1100 35.8 9.1 0.25 26.69 
17 12.09 25.6 97.6 855 98 1195 30.06 12.22 0.27 27.77 
18 12.55 33.57 98.9 756 96.67 989 35.6 8.56 0.28 8.69 
19 13.01 26.2 96.8 585 98.7 927 29.86 10.96 0.29 16.62 
20 13.21 30.32 97.87 610 98.86 1111 35 8.1 0.3 28 
21 13.23 31 97.33 707 96 1100 28.46 13.9 0.3 23.84 
22 15 30.03 96 727 97.5 1068 33.08 9 0.32 24.31 
23 15.45 30.55 97.42 505.5 97.54 767 32.65 12.66 0.33 6.75 
24 15.55 16.62 95 672 95 1051 37.7 8.15 0.33 15.52 
25 15.56 28.86 99 690 98.5 938 30.5 11.6 0.33 5.55 
26 15.58 31.58 95.68 601 98.26 983 31.66 9.87 0.34 23.43 
27 16.21 32.42 98.5 800 98 1250 32 9.66 0.35 12.21 
28 16.51 15.6 97 823 98 1216 36.58 12.29 0.57 8.27 
29 17.28 34.31 97 859 95.8 1112 30.12 11.56 0.9 5.89 
30 17.65 31.41 99 769 98.35 1067 31.27 11 0.98 6.58 
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IV.DISCUSSION: 
 Effect of adaptive radiotherapy in head and neck cancers is long been 
considered as a means to produce accurate dose delivery to the planned target 
volume  variations in the anatomy due to shrinkage of the tumor volume and 
positional error all have an overall impact in the treatment of head and neck 
cancers. The effect of  radiation on gross tumor volume happens at about  20
th
 
fraction of radiation /40 Gy tumor dose . Most of  our patients showed a gross 
reduction in the tumor volume. 
A.Planning target volume initial vs replan:  
 From our study  involving 30 patients,we observed that the mean PTV value 
of initial planning  CT was around 1070.58cc.The median PTV for initial plan was 
1076.50 cc . The minimum PTV for initial plan is around 767 cc . The maximum 
PTV for initial plan is 1331 cc. After the completion of 40 Gy in 20 # fractions,we 
observed a gross reduction in the volume of the GTV from our weekly CBCT 
images by assessing other morphological changes.The mean volume of the PTV in 
the replan CT(CBCT) was measured to be 694.55cc.The median volume of the 
PTV  in CBCT images is 687.0 , the minimum target volume in CBCT image is 
around 439.0 , the maximum target volume in CBCT image is 1001.0cc. 
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 From this observation ,we found that most of the patients exhibited 
significant reduction in the PTV after the completion of 40Gy.Thus ,this study 
helped us to investigate the effect of dose distribution on the PTV and the close 
lying OARs namely parotids in our study. 
 As the parotids are located peripherally to the tumours,any shrinkage in the 
tumour volume resulted in the parotids,sinking into the treatment field. 
 In IMRT treatment we always happen to limit the dose to the 
OARs(parotids) just at the tolerance limits,due to its anatomical location.The 
ability of  IMRT to sculpt the dose and take shapes avoiding parotids,can be 
appreciated very much in the treatment plans.After approving the plan,which has 
already met the dose volume objectives of the OARs and PTV,we assume mostly 
that the same has been delivered but due to tumour regression and other 
factors,including morphological changes,we end up in blindfolding ourselves from 
retrieving and correcting for the dosimetric impact of the structures. 
 Considering the effect of parotids sinking into the treatment fields at 40 Gy 
due to various factors listed above ,we studied volume regression and dose 
distortion based on CBCT data acquired at 40 Gy.  
 We analysed the PTV volumes in CBCT data sets and the effect of it in 
OARs dose increase. We calculated the normal tissue complication probability for 
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parotids based on a MAT LAB programme which,calculated the parotids’ NTCP 
based on the EUD obtained from the DVH data. 
 The following results were observed in NTCP (normal tissue complication 
probability) increase,in case of replan as been initiated for the dodse deposition on 
the parotids.The NTCP of parotids,for the initial planning CT plans are as follows, 
 
Statistics 
 PTV2 V95 PTV2 VOL CC 
N 
Valid 30 30 
Missing 0 0 
Mean 97.0980 694.556667 
Median 97.0000 687.000000 
Minimum 95.00 439.0000 
Maximum 99.99 1001.0000 
 
Statistics 
 PTV1 V95 PTV1 VOL CC 
N 
Valid 30 30 
Missing 0 0 
Mean 97.4317 1070.580000 
Median 97.9000 1076.500000 
Minimum 93.23 767.0000 
Maximum 99.06 1331.0000 
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 All the above values on paired T test was found to have a significant p value 
of <.0001which is statistically significant in our study.  
B.NTCP for CT Vs CBCT : 
  The mean NTCP of parotids for the initial planning CT plan for parotid is 
about 0.289%  ,the median NTCP of parotids for initial planning CT plan was 
0.245% , maximum NTCP of parotids received by the initial plan for the parotid is 
about 0.980% . 
Statistics 
 NTCP CT NTCP CBCT 
N 
Valid 30 30 
Missing 0 0 
Mean .289300 18.391067 
Median .245000 20.035000 
Minimum .0000 .0620 
Maximum .9800 29.5800 
 
  When the same initial plan is continued till 40 Gy the dose recived by the 
parotids show a significant difference , i.e., the mean dose received by the parotids 
in CBCT image contoured sets is 18.39 Gy , median dose received by the parotids 
in CBCT is 20.03 Gy , the  maximum dose received by the parotids if the same 
initial plan is continued can go high upto 29.58 Gy.  
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 These values are then calculated for the p value which is very much 
significant P<0.0001 .  
C. Planning target volume V95% :  
 V95%  is defined as the 95 % of the planned target volume receiving equal 
or more than 95 % of the prescribed dose .  
 The mean PTV V95% for initial plan  and  V 95% for the plan done in the 
replanning CBCT image is 97.43% and 97.09% respectively. The median volume 
of PTV receiving equal or greater tha 95% of the prescribed dose when compared 
between the initial plan and also the replanning CBCT image is 97.90% and 
97.00%  respectively. The maximum PTV  V95% for initial plan is around 99.06 
and 99.99  for replanning CBCT image set .  
 When these variables are calculated for the p value using the paired t test it 
did not turn out with significant p values . Thus from this we infer that although 
there were changes with respect to the volume of the planned target and the parotid 
moving into the field the planning target volume V 95%  dose received by the 
initial plan and the replanning CBCT does not show much of a difference. Thus the 
p value is not statistically significant in this case which means that even though 
replanning is done at 40 Gy the dose to be received by the planned target will not 
be  significantly reduced or affected . This means that the effect of adaptive 
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radiotherapy has much significant role to play when it comes to reducing the 
normal tissue complication and especially, the dose received by the parotids 
(which reciprocates in terms of reduction of xerostomia in patients who had 
adaptive radiotherapy).  
D.Spinal cord: 
Statistics 
 CORD GY INITIAL CORD GY REPLAN 
N 
Valid 30 30 
Missing 0 0 
Mean 32.430667 10.828333 
Median 32.325000 10.940000 
Minimum 27.5600 7.5500 
Maximum 38.2200 15.2800 
 
The initial plan for the spinal cord had a mean dose of 32.32 Gy and the mean dose 
for the spinal cord in replanning cone beam CT image is around 10.94 Gy. Thus 
the total point dose of the parotid was not more than 45 Gy in all the patients 
included in this study. 
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V. Conclusion: 
 Adaptive replanning is must for head and neck cancers at 40 Gy to evaluate 
the dose that is received by the tumour area in contrast to the dose received by the 
organs at risk. Continuing radiotherapy without replanning leads to dosimetrical 
errors in dose distribution to the planning target volume, which in turn leads to 
inappropriate high doses to the normal structures, and leads to increase in 
morbidity of the same.  Also, in high volume centres, cone beam computed 
tomography provides an efficient option in assessing the tumour response along 
with dose comparison to both tumour area and organs at risk.  Replanning at 40 Gy 
takes into account the tumor regression , nutritional status of the patient and body 
mass index and hence helps in replanning dose to the planning target volume 
thereby improving the treatment response and also reducing treatment related 
morbidity, thereby resulting in improved quality of life.  
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